Research coauthored by RTI Health Solutions researchers will be presented at the 2022 American Society of Clinical Psychopharmacology.
Risk of mortality associated with Pimavanserin compared with atypical antipsychotics in patients with Parkinson's disease–related psychosis. Layton JB, McQuay L, Forns J, Danysh HE, Dempsey C, Anthony MS, Turner ME.
Late Breaking Poster, Th59
Poster Session II
Thursday, June 2, 12:30 - 2:00 pm (MT)
Presentation to be given by Bradley Layton.
